Search results
Amgen (NASDAQ:AMGN) Price Target Raised to $332.00 at Royal Bank of Canada
ETF DAILY NEWS· 4 days agoAmgen (NASDAQ:AMGN – Free Report) had its target price hoisted by Royal Bank of Canada from $328.00 to $332.00 in a research report sent to investors on Friday, Benzinga reports. Several other ...
11 Best eye cream for dark circles
Associated Press· 7 days agoFeeling sleepy and want to eliminate tired-looking under-eye bags at home? We asked a dermatologist to help us pick out the best eye creams for dark...
Traders Purchase Large Volume of Call Options on Arcutis Biotherapeutics (NASDAQ:ARQT)
ETF DAILY NEWS· 4 days agoArcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) saw unusually large options trading on Thursday. Stock traders bought 10,057 call options ...
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) CEO Dinesh V. Ph D. Patel Sells 35,000 Shares of Stock
ETF DAILY NEWS· 7 days agoProtagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) CEO Dinesh V. Ph D. Patel sold 35,000 shares of the firm’s stock in a transaction dated Friday, June 7th. The stock was sold at ...
Sanibel Captiva Trust Company Inc. Invests $41.99 Million in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoSanibel Captiva Trust Company Inc. acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Gateway - Quartz
Quartz· 16 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar drug that dominates a market, brings in hordes of customers, and deposits hefty profits in ...
Optimist Retirement Group LLC Acquires Shares of 1,088 Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoOptimist Retirement Group LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with ...
Small company pursuing COVID-killing light therapy has atypical benefactor — NC lawmakers
The News & Observer· 6 days agoState legislative leaders two years ago tucked $6 million into the state budget for a newly formed company developing a novel COVID treatment — a device that would shine a ...
Nektar Therapeutics (NASDAQ:NKTR) Director Sells $23,400.00 in Stock
ETF DAILY NEWS· 3 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) Director Robert Chess sold 19,500 shares of Nektar Therapeutics stock in a transaction on Friday, June 14th. The shares were sold at an average ...
